Company Filing History:
Years Active: 2006
Title: Ken-ichi Suzumura: Innovator in Depsipeptide Compounds
Introduction
Ken-ichi Suzumura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases associated with histone deacetylases (HDAC).
Latest Patents
One of his key patents is related to a depsipeptide compound. This novel compound is useful as an agent for the prevention and treatment of diseases associated with HDAC, especially tumor or cell proliferative diseases. The depsipeptide compound or its pharmaceutically acceptable salt exhibits good HDAC inhibitory activity and inhibits cell proliferation against human cancer cells. Therefore, it holds promise for the treatment and improvement of diseases linked to histone acetylation.
Career Highlights
Ken-ichi Suzumura is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for serious health conditions, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with notable colleagues such as Koji Nagai and Masatoshi Taniguchi, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ken-ichi Suzumura's work in developing depsipeptide compounds represents a significant advancement in the treatment of diseases associated with HDAC. His contributions to the pharmaceutical industry are invaluable and continue to impact the field positively.